Spravato: Release Date, Cost, Ingredients for Ketamine-Based Nasal Anti-Depressant

Pluralism / Mar 06, 2019 - Source: inverse

On Tuesday, March 5, the FDA declared the ketamine-based nasal spray to be a safe and effective way to treat depression, and research shows the drug can be effective in hours instead of weeks. The results are credited to the use of esketamine, one of ...

Read full story >>

Ακολούθησε το pluralism.gr στο Instagram για αποκλειστικό περιεχόμενο!